The medications that can cause severe liver damage include even such widespread pharmaceuticals as paracetamol. Simultaneously, the advertisement and unrestricted sale of medication works towards its very wide application. Uncontrolled use of paracetamol is associated with a high risk of complications. According to data from medical centers in the USA and the UK, overdoses of paracetamol is one of the main causes of acute hepatic failure, which results in the death of patients in many cases.

When analyzing the results obtained, one can state that the use of the enterosorbent Enterosgel after intoxication with paracetamol most efficiently decreases the LPO processes in the one- and twelve-month old white rats. The plasma level of MDA in the six-month old white rats of all groups under study did not change significantly compared to the one- and twelve-month old animals. This is evidence of high adaptive resources of adult organisms under the condition of influence of exogenous xenobiotics.

Clinical evidences

1. Babak O. Ya. Modern concepts of drug-induced damage of liver // Zdorov’ya Ukraini [Health of Ukraine]. — 2007. — No. 20 (1). — PP. 34-36.

2. Belyaeva O.A., Semenov V.G. Enterosorption in the complex therapy of different liver diseases // Mistetstvo likuvaniya [Art of Treatment]. — 2005. — No. 7(023). — PP. 48-49.

3. Bueverov A.O. Archakov A.I. Drug-induced damages of liver // Russ. Med. Zh. [Russ. Med. J.] — 2001. — No. 9. — PP. 13-14.

4. Viktorov A.P. This “new-old paracetamol” // Sovrem. probl. Toksikologii [Modern Problems of Toxicology]. — 1998. — No. 2. — PP. 8789.

5. Gavrilov V.B., Gavrilova A.P., Mazhul’ L.M. Analysis of the methods for determination of the lipid peroxidation products in the blood serum by the test with thiobarbituric acid // Vopr. med. khimii [Problems of Med. Chem.]. — 1987. — V. 33, No. 1. — PP. 118-122.

6. Doklinichni doslidzhennya likars’kikh zasobiv. [Preclinical studies of drug-induced diseases]: Practical guidelines / Ed. O.V. Stephanova. — Kiev: Ministry of Health of Ukraine, State Pharmacological Centre, 2001. — 527 pp.

7. Kozhem’yakin Yu.M., Khromov O.S., Filonenko M.A., Saifetdinova G.A.. Scientific practical guidelines for keeping of laboratory animals. — Kiev: Avitsenna, 2002. — 156 pp.

8. Korolyuk M.A., Ivanova L.I., Maiorova I.G et al. Determination of catalase activity // Lab. Delo [Laboratory art]. — 1988. — No. 1. — PP. 16-19.

9. Lankin T.F. Biometriya [Biometrics]. — Moscow: Vyssh. shk., 1990. — 352 pp.

10. Makarevich O.P., Golikov P.P. Activity of blood superoxide dismutase in acuity of different diseases // Lab. Delo [Laboratory art]. — 1983. — No 6. — P. 24-27.

11. Stal’naya I.D. Methods for determination of diene conjugation of unsaturated higher fatty acids // Sovrem. metody v biokhimii [Modern Methods in Biochemistry] / Ed. V.N. Orekhovicha. — Moscow.: Medicine, 1977. — PP. 63-64.

12. Shevchenko Yu.N. Organosilicone sorbents. Properties and field of application. Enterosgel and complex medications based on it // Sb. rabot po primeneniyu preparata “Enterosgel” v meditsine [Collection of works on medical application of “Enterosgel”]. — Part. I. — Мoscow., 2002. — PP. 3-12.

13. Bessems J.G., Vermeulen N.P. Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches // Crit. Rev. Toxicol. — 2001.

— V. 31. — Р. 55-138.

14. Carrasco R., Perez Mateo M., Gutierrez A. Effect of different doses of S-ade- nosyl-L- methionine on paracetamol hepatotoxicity in a mouse model. Methods Find Exp.Clin. Pharmacol.

— 2000. — № 22 (10) — Р. 737-740.

15. Jones A.L. Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning: a critical review // J. Toxicol. Clin. Toxicol. — 1998. — V. 36 (4).

— P. 277-285.

16. Larson A.M., Poison J., Fontana R.J. et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study // Hepatology. — 2005. — Vol. 42. — Р. 1364-1372.

17. Marino G., Limmerman HJ . Management of drug-induced liver disease // Cur. Gastr. Reports. — 2007. — Vol. 3. — P. 38-48.

UDK 615.212.099-06:616.15:612.015.11-085.246.9]-092.9